Sat Kartar Shopping Limited is acquiring the remaining stake in Plantomed Neutraceuticals Private Limited for ₹1.21 Crore to make it a wholly-owned subsidiary. The acquisition of the Ayurveda healthcare company aims to consolidate brands and expand the product portfolio. The transaction is expected to be completed by May 15, 2026.
Sat Kartar Shopping Limited approved the acquisition of a further 24% stake in Plantomed Neutraceuticals Private Limited for ₹1.21 Crore. This transaction will increase the company's control to 100%, making the target a wholly-owned subsidiary. The acquisition aims to consolidate branding and expand the company's Ayurveda and wellness product portfolio by May 2026.
Sat Kartar Life Limited approved the acquisition of an additional 24% stake in Plantomed Nutraceuticals Private Limited for ₹1.21 Crore. The transaction will make the target a wholly-owned subsidiary, aiding brand consolidation and aligning operations with the company's long-term vision. The deal is expected to close by May 15, 2026.
